Day: December 15, 2022

STUART, Fla., Dec. 15, 2022 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) (NASDAQ: SBCF) announced that its Board of Directors (the “Board”) has renewed the Company’s share repurchase program. Under the repurchase program, which will expire on December 31, 2023, the Company may repurchase, from time to time, up to $100 million of its shares of common stock, representing approximately 4% of the Company’s outstanding common stock. The repurchase program permits shares to be repurchased in the open market, by block purchase, in privately negotiated transactions, in one or more transactions from time to time, or pursuant to any trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the “Exchange Act”). Open market purchases will be conducted in accordance...

Grants from Department of Water Resources to Support Disadvantaged Communities SAN JOSE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) — Grant funding from the State of California’s Department of Water Resources (DWR) to the County of Tulare will enable local water provider California Water Service (Cal Water) to connect two small, disadvantaged communities struggling with failing domestic wells with its Visalia system. The consolidation is intended to help ensure residents in West Goshen and on Harrison Road receive a reliable supply of safe, clean water for years to come. While 80 customers that had been part of West Goshen Mutual Water Company were added to Cal Water’s system in 2014, another 50 residences in West Goshen had domestic wells and were not part of West Goshen Mutual and the original consolidation. Through DWR’s Small Community...

Experienced biotech executive to lead the next phase of growth ADELAIDE, Australia, Dec. 15, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that it has appointed Spyridon “Spyros” Papapetropoulos, M.D. as President and Chief Executive Officer (CEO), effective 5 January 2023. Errol B. De Souza, Ph.D., who has been serving as Bionomics’ Executive Chairman since November 2018, will continue in his role through 31 December 2022 to ensure a seamless transition, and will resume the role of Non-Executive Chairman of the Board of Directors effective...

Emraclidine is being developed as a potential once-daily treatment for schizophrenia without the need for titration Data show clinically meaningful and statistically significant improvement with emraclidine in PANSS total score at six weeks and was overall well-tolerated compared with placebo Results demonstrate selective targeting of the M4 muscarinic receptor subtype as a potential novel treatment approach for schizophrenia Comprehensive Phase 2 development program in schizophrenia currently underway CAMBRIDGE, Mass., Dec. 15, 2022 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the publication of data from its Phase 1b clinical trial of emraclidine, a novel muscarinic M4 selective positive allosteric modulator,...

New York, NY, Dec. 15, 2022 (GLOBE NEWSWIRE) — Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“Sagaliam” or the “Company”) announced today that its special meeting of stockholders (the “Meeting”), which was originally scheduled for Friday, December 16, 2022, has been adjourned to 9:00 a.m., Eastern Time, on December 22, 2022. At the Meeting, stockholders will be asked to vote on a proposal to amend the Company’s amended and restated certificate of incorporation (the “Charter”) pursuant to a first amendment to the Charter to provide the Company with the option to extend the date by which the Company must complete its initial business combination from December 23, 2022 by up to ten successive one month periods up to October 23, 2023 by depositing additional funds into the trust account at each extension election (the...

MARKHAM, Ontario, Dec. 15, 2022 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of December 2022, which is payable on January 16, 2023 to shareholders of record at the close of business on December 30, 2022. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide contract services...

TORONTO, Dec. 15, 2022 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced a distribution of 8.5 cents per unit for the month of December. The distribution will be payable on January 9, 2023 to unitholders of record as at December 30, 2022. About RioCanRioCan is one of Canada’s largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. As at September 30, 2022, our portfolio is comprised of 198 properties with an aggregate net leasable area of approximately 34.8 million square feet (at RioCan’s interest) including office, residential rental and 11 development properties. To learn more about us, please visit www.riocan.com.CONTACT:...

Not for distribution to U.S. newswire services or for dissemination in the United States. CALBGARY, Alberta, Dec. 15, 2022 (GLOBE NEWSWIRE) — Northview Fund (the “Fund”) today announced its December 2022 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units Class (collectively, the “Units”), payable on January 16, 2023 to holders of Units of record at December 31, 2022. The distribution amounts will be as follows:C$0.10476 per Class A Unit, representing approximately C$1.26 per Unit on an annualized basis; C$0.11056 per Class C Unit, representing approximately C$1.33 per Unit on an annualized basis; C$0.10807 per Class F Unit, representing approximately C$1.30 per Unit on an annualized basis;About Northview Fund The Fund is a “closed-end fund” established pursuant to a declaration of trust...

CALGARY, Alberta, Dec. 15, 2022 (GLOBE NEWSWIRE) —  Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to December 2022 of $0.05 per common share is to be paid on January 13, 2023, for shareholders of record on December 31, 2022. The ex-dividend date for the December dividend is December 29, 2022. Starting January 2023, the monthly dividend will increase to $0.11 per common share and is to be paid on February 15, 2023, for shareholders of record on January 31, 2023. The ex-dividend date for the January dividend is January 30, 2023. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes...